Maze Therapeutics, Inc., a biopharmaceutical company focused on developing precision medicines for renal, metabolic, and cardiovascular diseases, announced that CEO Jason Coloma, Ph.D., will present a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback